4.5 Article

A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy

Related references

Note: Only part of the references are listed.
Article Oncology

The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

Koki Obayashi et al.

Summary: The study evaluates the potential of Lung Immune Prognostic Index (LIPI) as a preoperative biomarker for patients with bladder cancer, showing LIPI can predict the prognosis of patients undergoing radical cystectomy and has better predictive ability when combined with pT3/4 and lymph node metastasis.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Oncology

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio

Soo Jin Lee et al.

Summary: The preoperative neutrophil-lymphocyte ratio (NLR) is significantly associated with increased risk of recurrence and death in rectal cancer patients receiving preoperative chemoradiotherapy. However, postoperative NLR does not have a significant correlation with these outcomes. Further studies are needed to confirm the prognostic value of NLR in this patient population.

FRONTIERS IN ONCOLOGY (2022)

Article Surgery

A good preoperative immune prognostic index is predictive of better long-term outcomes after laparoscopic gastrectomy compared with open gastrectomy for stage II gastric cancer in elderly patients

Guo-Sheng Lin et al.

Summary: The study found that the immune prognostic index is closely related to the long-term prognosis of elderly gastric cancer. Compared with OG, LG may improve the 5-year survival rate of patients with stage II gastric cancer. This hypothesis needs to be further confirmed by future prospective studies.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)

Article Oncology

Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation

Huajun Cai et al.

Summary: The study showed that LODDS is a better prognostic factor for CSS in colon MAC patients. Diagnostic criteria based on LODDS and RPA staging can provide accurate information for personalized cancer treatment.

CANCER MEDICINE (2021)

Article Oncology

LDH-A negatively regulates dMMR in colorectal cancer

Yongjie Zhang et al.

Summary: LDH-A can promote the proliferation of dMMR and pMMR CRC cells by positively regulating MMR proteins, LDH-A inhibition may improve the efficacy of PD-1 blockade, a significant correlation between LDH-A and dMMR status was observed in 186 CRC specimens, LDH-A and dMMR double-low patients showed better disease-free survival.

CANCER SCIENCE (2021)

Review Biochemistry & Molecular Biology

Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients

Takehito Yamamoto et al.

Summary: Colorectal cancer is the leading cause of cancer deaths globally, and inflammation-related prognostic markers have significant impact on the prognosis of CRC patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data

Ye Wang et al.

Summary: The study found that tumor size, WHO grade, and depth of tumor invasion are independent risk factors for lymph node metastasis in rectal neuroendocrine tumors. A model has been developed to predict the risk of LNM and identify suitable patients for local resection.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Oncology

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

Chun-Ming Huang et al.

Summary: The study found that a high neutrophil-to-lymphocyte ratio (NLR) before treatment (>= 3.2) was an independent predictor of reduced overall survival and disease-free survival in locally advanced rectal cancer patients who achieved a pathological complete response to neoadjuvant chemoradiotherapy. High NLR was significantly associated with tumor recurrence and could serve as a promising predictor for poor outcomes in this patient population.

CANCERS (2021)

Article Gastroenterology & Hepatology

Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When

Georgios Karagkounis et al.

DISEASES OF THE COLON & RECTUM (2019)

Article Oncology

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Benjamin Weide et al.

CLINICAL CANCER RESEARCH (2016)

Article Oncology

Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer

S. Gollins et al.

CLINICAL ONCOLOGY (2016)

Review Biochemistry & Molecular Biology

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Yi Li et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)

Article Oncology

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

Sander Kelderman et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)

Article Oncology

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer

M. J. Proctor et al.

BRITISH JOURNAL OF CANCER (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Editorial Material Oncology

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge et al.

ANNALS OF SURGICAL ONCOLOGY (2010)